SCHEMBL27658163

SCHEMBL27658163

[CH2]Cc1n[nH]cc1[N+](=O)[O-]

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.35
GPR35 Q9HC97 1/20 0.33
AR P10275 1/20 0.33
NPC1 O15118 1/20 0.32
RECQL P46063 1/20 0.32
RAB9A P51151 1/20 0.32
KDM4E B2RXH2 2/20 0.32
CYP3A4 P08684 3/20 0.31
MAPT P10636 3/20 0.31
CYP1A2 P05177 2/20 0.31
TSHR P16473 2/20 0.31
BLM P54132 2/20 0.31
GRIN2D O15399 1/20 0.31
GRIN3B O60391 1/20 0.31
HPGD P15428 1/20 0.31
GRIK1 P39086 1/20 0.31
GRIA1 P42261 1/20 0.31
GRIA2 P42262 1/20 0.31
GRIA3 P42263 1/20 0.31
GRIA4 P48058 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2556010 0.80 GAA (0.40) LMNAGPR35KDM4EMAPTALDH1A1
SCHEMBL22609628 0.80 LMNA (0.35) LMNAGPR35ARNPC1RECQL
SCHEMBL9354801 0.80 LOXL2 (0.35) LMNAGPR35ARNPC1RECQL
SCHEMBL22118876 0.79 ALDH1A1 (0.35) LMNAGPR35ARKDM4ECYP3A4
SCHEMBL28275491 0.77 PIM3 (0.39) LMNAKDM4EMAPTTSHRALDH1A1
SCHEMBL2227139 0.76 TXNRD1 (0.34) LMNAGPR35ARCYP3A4MAPT
SCHEMBL2554640 0.76 AR (0.33) LMNAGPR35ARNPC1RECQL
Hydrochloric Acid SCHEMBL30781517 0.76 LMNA (0.33) LMNAGPR35ARNPC1RECQL
SCHEMBL27718449 0.76 CYP1A2 (0.42) LMNAGPR35MAPTCYP1A2TSHR
SCHEMBL1559568 0.74 LMNA (0.49) LMNAGPR35RAB9AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1826323-B 3, 4-disubstituted 1H-pyrazole compounds and their use as modulators of Cyclin Dependent Kinases (CDKs) and glycogen synthase kinase-3 (GSK-3) ASTEX THERAPEUTICS LTD 2012-06-27 CN disclosed
CN-101146533-A Combinations of pyrazole kinase inhibitors and further antitumor agents ASTEX THERAPEUTICS LTD (GB) 2008-03-19 CN disclosed
CN-101146531-A Pharmaceutical compounds ASTEX THERAPEUTICS LTD (GB) 2008-03-19 CN disclosed
CN-1826323-A 3, 4-disubstituted 1H-pyrazole compounds and their use as modulators of Cyclin Dependent Kinases (CDKs) and glycogen synthase kinase-3 (GSK-3) ASTEX THERAPEUTICS LTD (GB) 2006-08-30 CN disclosed